These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20177069)

  • 1. Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
    Miralem T; Gibbs PE; Revert F; Saus J; Maines MD
    J Biol Chem; 2010 Apr; 285(17):12551-8. PubMed ID: 20177069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.
    Gibbs PE; Miralem T; Maines MD
    FASEB J; 2010 Sep; 24(9):3239-54. PubMed ID: 20410444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.
    Gibbs PE; Maines MD
    Int J Cancer; 2007 Dec; 121(11):2567-74. PubMed ID: 17683071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
    Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
    J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.
    Miralem T; Lerner-Marmarosh N; Gibbs PE; Tudor C; Hagen FK; Maines MD
    J Biol Chem; 2012 Jul; 287(29):24698-712. PubMed ID: 22584576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
    Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
    FASEB J; 2007 Dec; 21(14):3949-62. PubMed ID: 17639074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
    Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
    Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
    FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.
    Kravets A; Hu Z; Miralem T; Torno MD; Maines MD
    J Biol Chem; 2004 May; 279(19):19916-23. PubMed ID: 14988408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
    Maines MD; Miralem T; Lerner-Marmarosh N; Shen J; Gibbs PE
    J Biol Chem; 2007 Mar; 282(11):8110-22. PubMed ID: 17227757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.
    Tudor C; Lerner-Marmarosh N; Engelborghs Y; Gibbs PE; Maines MD
    Biochem J; 2008 Aug; 413(3):405-16. PubMed ID: 18412543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis.
    Raya A; Revert-Ros F; Martinez-Martinez P; Navarro S; Rosello E; Vieites B; Granero F; Forteza J; Saus J
    J Biol Chem; 2000 Dec; 275(51):40392-9. PubMed ID: 11007769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein.
    Granero F; Revert F; Revert-Ros F; Lainez S; Martínez-Martínez P; Saus J
    FEBS J; 2005 Oct; 272(20):5291-305. PubMed ID: 16218959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
    Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
    J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane.
    Revert F; Merino R; Monteagudo C; Macias J; Peydró A; Alcácer J; Muniesa P; Marquina R; Blanco M; Iglesias M; Revert-Ros F; Merino J; Saus J
    Am J Pathol; 2007 Nov; 171(5):1419-30. PubMed ID: 17916599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens.
    Olson CM; Hedrick MN; Izadi H; Bates TC; Olivera ER; Anguita J
    Infect Immun; 2007 Jan; 75(1):270-7. PubMed ID: 17074860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway.
    Jamaluddin M; Wang S; Boldogh I; Tian B; Brasier AR
    Cell Signal; 2007 Jul; 19(7):1419-33. PubMed ID: 17317104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.
    Sakurai H; Suzuki S; Kawasaki N; Nakano H; Okazaki T; Chino A; Doi T; Saiki I
    J Biol Chem; 2003 Sep; 278(38):36916-23. PubMed ID: 12842894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.